Supplemental Material: Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.

Articles in this issue

---

Use of COTA Nodal Address Highlights Variance in Cancer Care Cost: An Interview With Donald M. Berwick, MD, MPP

Radiation Oncology’s Role in the Next Chapter of Payment Reform

ACCC and ASCO Collaborative Targets Disparities in Cancer Clinical Trials

Flying the Plane While You Build It

The Untapped Potential of Cell and Gene Therapy

Interview: Tanya Siddiqi, MD, Discusses the Promise of Reduced Toxicity With Liso-Cel

FDA Approves Osimertinib for Adjuvant Treatment of Early-Stage EGFR-Mutated NSCLC

Certain NSCLC Patients Are More Likely to Respond to Immunotherapy, Study Results Show

Possible Treatment Identified for Aggressive NSCLC Subset

Contributor: A Practical Path Forward to More Patient-Centered Value Assessment

Proximity to Treatment, Racial Disparities Are Seen in Ovarian Cancer Survival

Lung Cancer Screenings Fall, Biopsy Rates Rise During COVID-19

As Mammography Screenings Drop, Advanced Breast Cancer Cases Increase in First Months of COVID-19

Azacitidine Is Shown to Improve Overall, Relapse-Free Survival in Older Adults With AML

FDA Updates Ibrutinib Label With 5-Year Data in Waldenström Macroglobulinemia

Related Videos

Related Content

Advertisement

July 18th 2025

Assertive Community Treatment for Complex and Costly Patients

Trygve Dolber, MD Patrick Runnels, MD, MBA Peter J. Pronovost, MD, PhD

Assertive community treatment, a strongly evidence-based practice for delivering care to individuals with schizophrenia and low health care engagement, is applicable to disengaged, medically complex patients.

March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.

July 14th 2025

Medicare Inflation Rebates Show Limited Impact on Drug Price Trends

Brooke McCormick

Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Maggie L. Shaw

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

July 9th 2025

Trends in Market Share Among Hospitals Participating in ACOs and Nonparticipants

Mariétou H. Ouayogodé, PhD Xiaodan Liang, MS David B. Muhlestein, PhD, JD

Accountable care organization (ACO) participation was associated with an increase in hospitals’ mean market share and with additional market share gains in more concentrated markets.

July 8th 2025

Practical Considerations for AI in Community Oncology

Mary Caffrey

Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."

Related Content

Advertisement

July 18th 2025

Assertive Community Treatment for Complex and Costly Patients

Trygve Dolber, MD Patrick Runnels, MD, MBA Peter J. Pronovost, MD, PhD

Assertive community treatment, a strongly evidence-based practice for delivering care to individuals with schizophrenia and low health care engagement, is applicable to disengaged, medically complex patients.

March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.

July 14th 2025

Medicare Inflation Rebates Show Limited Impact on Drug Price Trends

Brooke McCormick

Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Maggie L. Shaw

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

July 9th 2025

Trends in Market Share Among Hospitals Participating in ACOs and Nonparticipants

Mariétou H. Ouayogodé, PhD Xiaodan Liang, MS David B. Muhlestein, PhD, JD

Accountable care organization (ACO) participation was associated with an increase in hospitals’ mean market share and with additional market share gains in more concentrated markets.

July 8th 2025

Practical Considerations for AI in Community Oncology

Mary Caffrey

Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."